Literature DB >> 2526608

Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis.

J R Spurzem1, C Saltini, M Kirby, K Konishi, R G Crystal.   

Abstract

Sarcoidosis is characterized by the accumulation of activated helper/inducer T-cells and macrophages at sites of disease. The accumulation of these T-cells may be related to the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocyte proliferation in an exaggerated fashion. In the context that HLA Class II gene (HLA-DR, DQ, and DP) expression is essential to the interaction of lymphocytes with antigen-presenting cells such as macrophages, we have evaluated the hypothesis that the expression of Class II genes may be up-regulated in sarcoid alveolar macrophages. Northern blot and dot blot analysis with 32P-labeled cDNA probes for HLA-DR, DQ, and DP genes revealed that both normal and sarcoid alveolar macrophages contain Class II mRNA transcripts, but that the levels in sarcoid and normal alveolar macrophages are similar (p greater than 0.3, all comparisons). Furthermore, evaluation of surface expression of Class II molecules with monoclonal antibodies and flow cytometry analysis demonstrated that alveolar macrophages of both patients with sarcoidosis and normal subjects express all three Class II molecules, DR, DQ, and DP, but there were no significant differences between sarcoid patients and normal subjects in the proportions of macrophages expressing these surface molecules. However, there was a significantly higher surface density of Class II molecules on sarcoid alveolar macrophages (p less than 0.05, all comparisons sarcoid to normal).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526608     DOI: 10.1164/ajrccm/140.1.89

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Ontogeny of macrophage subpopulations and Ia-positive dendritic cells in pulmonary tissue of the rat.

Authors:  E P van Rees; M B van der Ende; T Sminia
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

2.  Reduction in HLA-DR antigen density on alveolar macrophages of smokers.

Authors:  W Pankow; K Neumann; J Rüschoff; R Schröder; P von Wichert
Journal:  Lung       Date:  1991       Impact factor: 2.584

3.  Normal and sarcoid alveolar macrophages differ in their ability to present antigen and to cluster with autologous lymphocytes.

Authors:  V A Gant; Z Shakoor; I L Barbosa; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 4.  Molecular profiling in sarcoidosis.

Authors:  Nicholas K Arger; Brian O'Connor; Laura L Koth
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

5.  Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.

Authors:  Ronit Mazor; Selamawit Addissie; Youjin Jang; Chin-Hsien Tai; Jeremy Rose; Fran Hakim; Ira Pastan
Journal:  AAPS J       Date:  2016-10-27       Impact factor: 4.009

Review 6.  Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins.

Authors:  Ronit Mazor; Emily M King; Ira Pastan
Journal:  Am J Pathol       Date:  2018-06-02       Impact factor: 4.307

7.  Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules.

Authors:  C J Chelen; Y Fang; G J Freeman; H Secrist; J D Marshall; P T Hwang; L R Frankel; R H DeKruyff; D T Umetsu
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

8.  Immunohistological analysis of sarcoid myopathy.

Authors:  D S Tews; D E Pongratz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 9.  Bronchoalveolar lavage.

Authors:  W R Martin; P A Padrid; C E Cross
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.